ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63

BACKGROUND: Rare prostate carcinomas aberrantly express p63 and have an immunophenotype intermediate between basal and luminal cells. Here, we performed gene expression profiling on p63-expressing prostatic carcinomas and compared them to usual-type adenocarcinoma. We identify ETS2 as highly express...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Prostate
Главные авторы: Torres, Alba, Alshalalfa, Mohammed, Davicioni, Elai, Gupta, Anuj, Yegnasubramanian, Srinivasan, Wheelan, Sarah J., Epstein, Jonathan I., De Marzo, Angelo M., Lotan, Tamara L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6818503/
https://ncbi.nlm.nih.gov/pubmed/29761525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23646
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы